A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Fate Therapeutics
Related studies linked through entity extraction aliases.
A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.
- Status
- TERMINATED
- Phase
- PHASE2
Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1